Lisinopril-d5
CAT:
804-HY-18206S
Size:
1 mg
For Laboratory Research Only. Not for Clinical or Personal Use.
Price:
Ask
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


Lisinopril-d5
Description:
Lisinopril-d5 is the deuterium labeled Lisinopril. Lisinopril (MK-521) is angiotensin-converting enzyme inhibitor, used in treatment of hypertension, congestive heart failure, and heart attacks.Product Name Alternative:
MK-521-d5UNSPSC:
12352005Hazard Statement:
H315, H319, H335, H361Target:
Angiotensin-converting Enzyme (ACE) ; Isotope-Labeled CompoundsType:
Isotope-Labeled CompoundsRelated Pathways:
Metabolic Enzyme/Protease; OthersField of Research:
Cardiovascular DiseasePurity:
96.0Solubility:
H2O : 50 mg/mL (ultrasonic; warming)Smiles:
[2H]C1=C([2H])C([2H])=C([2H])C([2H])=C1CC[C@@H](C(O)=O)N[C@@H](CCCCN)C(N2[C@@H](CCC2)C(O)=O)=OMolecular Formula:
C21H26D5N3O5Molecular Weight:
410.52Precautions:
H315, H319, H335, H361References & Citations:
[1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53 (2) :211-216. |[2]Andujar-Sanchez, M., V. Jara-Perez, and A. Camara-Artigas, Thermodynamic determination of the binding constants of angiotensin-converting enzyme inhibitors by a displacement method. FEBS Lett, 2007. 581 (18) : p. 3449-54.|[3]Song, J.C. and C.M. White, Clinical pharmacokinetics and selective pharmacodynamics of new angiotensin converting enzyme inhibitors: an update. Clin Pharmacokinet, 2002. 41 (3) : p. 207-24.Shipping Conditions:
Room TemperatureStorage Conditions:
4°C (Powder, protect from light)Scientific Category:
Isotope-Labeled CompoundsClinical Information:
No Development ReportedCAS Number:
1356905-39-9
